(Intervention) Recommending HPV vaccine for patients 9-10 years of age for Human Papillomavirus
Phase-Based Progress Estimates
Effectiveness
Safety
Human Papillomavirus(Intervention) Recommending HPV vaccine for patients 9-10 years of age - Behavioral
Study Summary
This trial will test whether earlier vaccination for HPV will result in less parental refusal and higher rates of full vaccination.
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 2 Secondary · Reporting Duration: post-intervention assessed in year 5 of study, year 4 of trial
Year 5
Age at completion of two dose HPV series
Age at initiation of the HPV series
HPV completion by age 13 years
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Providers recommending HPV vaccine at age 11-12 years of age
1 of 2
Providers recommending HPV vaccine at age 9-10 years of age
1 of 2
Active Control
Experimental Treatment
660 Total Participants · 2 Treatment Groups
Primary Treatment: (Intervention) Recommending HPV vaccine for patients 9-10 years of age · No Placebo Group · N/A
Providers recommending HPV vaccine at age 9-10 years of age
Behavioral
Experimental Group · 1 Intervention: (Intervention) Recommending HPV vaccine for patients 9-10 years of age · Intervention Types: BehavioralProviders recommending HPV vaccine at age 11-12 years of age
Behavioral
ActiveComparator Group · 1 Intervention: (Control) Recommending HPV vaccine for patients 11-12 years of age · Intervention Types: BehavioralTrial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: post-intervention assessed in year 5 of study, year 4 of trial
Who is running the clinical trial?
University of Colorado, DenverLead Sponsor
1,593 Previous Clinical Trials
1,926,906 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,077 Previous Clinical Trials
41,138,968 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,442 Previous Clinical Trials
24,579,831 Total Patients Enrolled
Allison Kempe, MD, MPHPrincipal InvestigatorUniversity of Colorado, Denver
11 Previous Clinical Trials
517,125 Total Patients Enrolled
Eligibility Criteria
Age 18+ · All Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:The practice is located in Metro Denver, Colorado and Metro Los Angeles, California.
Practices do not currently recommend HPV vaccination at 9-10 years.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments